维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="Gattaz"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory' 显示文摘	Schaeffer EL Gattaz WF	2005	Psychopharmacology ( Berl )2005，181，2：	1
2	Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2 显示文摘	Frieboes RM Moises HW Gattaz WF	2001	Am J Med Genet2001，105，3：	1
3	Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder 显示文摘	Nunes P V Forlenza O V Gattaz W F	2007	Br J Psychiatry2007，190，：	1
4	Vasopressin-oxytocin incerebro spinal fluid of schizophrenic patients and normal con-trols显示文摘	Beckmann H Lang RE Gattaz WF	1985	Psychoneuroendocrinology1985，10，2：	1
5	Long-term decrease in immediate early gene expression after electroconvulsive seizures显示文摘	Julien Braga Calais Samira S. Valvassori Wilson R. Resende Gustavo Feier Maria Carolina Pedro Athié Sidarta Ribeiro Wagner Farid Gattaz Jo?o Quevedo Elida Benquique Ojopi	2013	Journal of Neural Transmission2013，，2：	1
6	Vocational rehabilitation improves ognition and negative symptoms in schizophrenia显示文摘	Bio DS Gattaz WF	2011	Schizophr Res2011，126，13：	1
7	World Psychiatric Association Pharmacopsychiatry Section Statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia显示文摘	Tandon R Belmaker RH Gattaz WF	2008	Schizophr Res2008，100，1：	1
8	Body mass index increase,serum leptin,adiponectin,neuropeptide Y and lipid levels during treatment with olanzapine and haloperidol显示文摘	Raposo NR Ferreira AS Gattaz WF		0，，05：	1
9	Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease : Participation of the phospholipase A2 enzyme 显示文摘	Schaeffer EL Gattaz WF	2008	Psychophannacology ( Berl )2008，198，1：	1
10	Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial显示文摘	Gattaz W F Diehl A Geuppert M S	2004	Pharmacopsychiatry2004，37，6：	1
11	Pain perception threshold in major depression显示文摘	Adler G Gattaz W F	1993	Biol Psychiatry1993，34，10：	1
12	Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology – a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist显示文摘	H. Wetzel G. Gründer A. Hillert M. Philipp W. F. Gattaz H. Sauer G. Adler J. Schr?der W. Rein O. Benkert	1998	Psychopharmacology1998，，3：	1
13	Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease显示文摘	Schaeffer EL Forlenza OV Gattaz WF	2009	Psychopharmacology (Bed)2009，202，13：	1
14	Increased serum phospholipase A2 activity in schizophrenia:a replication study显示文摘	Gattaz WF Hubner CV Nevalainen TJ	1990	Biol Psychiatry1990，28，6：	1
15	Insights into Alzheimer disease pathogenesis from studies in transgenic an- imal models 显示文摘	Schaeffer E L Figueiro M Gattaz W F	2011	Cncs2011，66，1：	1
16	Diagnosis and biomarkers of predementia in Alzheimefs disease显示文摘	Forlenza O V Diniz B S Gattaz W F	2010	BMC Med2010，8，：	1
17	Aripiprazole for patients with schizophrenia and schizoaffective disorder:an open-label,randomized,study versus haloperidol显示文摘	de Oliveira IR Elkis H Gattaz WF	2009	CNS Spectr2009，14，2：	1
18	Diagnosis and biomarkers of predementia in Alzheimer’s disease显示文摘	Forlenza OV Diniz BS Gattaz WF	2010	BMC Med2010，8，1：	1
19	World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia显示文摘	Tandon R Belmaker RH Gattaz WF	2008	Schizophr Res2008，100，13：	1
20	Diagnosis and biomarkers of predementia in Alzheimer's disease显示文摘	Forlenza O V Diniz B S Gattaz W F	2010	BMC Med2010，8，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示